On the recordNovember 29, 2012
``Advances in the biological sciences have changed the way we view disease. We now recognize the dysfunction of specific biochemical pathways''--not disease-specific pathways--``biochemical pathways that govern cell behavior that may be similar in superficially disparate diseases or quite different in patients with the same disease. What they are saying to us, through this letter, is that, of course, they are going to do what we tell them to do. But the very intent of what we are wanting to accomplish is we are going to delay the outcome because we have not significantly, in the last 3 years, significantly increased NIH's budget. So limited dollars are going to be spent as directed through this recalcitrant bill that are not going to direct the translational research and biochemical pathway research they are in. I would just tell my colleagues in the next 10 years we are going to see such phenomenal changes in our approach to disease, and the treatments for that, and the reason we are going to see it is because we stop looking at diseases and started looking at translational genomics and biochemical pathways. I will be one of the few who vote against this. I am fine with a voice vote if no other colleagues object. I have no problems with that. But in the name of doing good I suggest that we are actually going to limit our ability to achieve, at a sooner time, the cures that everybody who is supporting this bill would like to see. I yield. The PRESIDING OFFICER.…





